Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type

Condition:   NK/T Cell Lymphoma Nos Intervention:   Drug: sintilimab,pegaspargase,gemcitabine,oxaliplatin Sponsor:   Sun Yat-sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials